Ahmad Al Sarraf Kuwait. Andreas Zirlik Germany

Size: px

Start display at page:

Download "Ahmad Al Sarraf Kuwait. Andreas Zirlik Germany"

Chloe Dennis
5 years ago
Views:

1 1

2 s 2

3 3

4 4

5 Ahmad Al Sarraf Kuwait Dr. A Sarraf is the Head of Laboratory department at the Kuwait Cancer Control Center in Kuwait. Dr. Al- Sarraf is member of the Clinical biochemistry committee in Kuwait and fellow of the Royal College of Physicians and Surgeons of Canada in Medical Biochemistry.

5 5 Ahmad Al Sarraf Kuwait Dr. A Sarraf is the Head of Laboratory department at the Kuwait Cancer Control Center in Kuwait. Dr. Al- Sarraf is member of the Clinical biochemistry committee in Kuwait and fellow of the Royal College of Physicians and Surgeons of Canada in Medical Biochemistry. He is also program director for clinical biochemistry program in Kuwait. Andreas Zirlik Germany Professor Zirlik is Professor for Cardiology and Chief of the Department of Cardiology at the LKH University Hospital of the Medical University of Graz, Austria. He is the current president of the German Atherosclerosis Society (DGAF), chairman of the working group of Heart and Diabetes of the German Cardiac Society (DGK).

6 Gerald Tomkin - Ireland Gerald Tomkin is president of Diabetes Ireland and has been a vice president of the European Association for the study of Diabetes (EASD) and president of the Association of

6 6 Gerald Tomkin - Ireland Gerald Tomkin is president of Diabetes Ireland and has been a vice president of the European Association for the study of Diabetes (EASD) and president of the Association of Physicians of Great Britain and Ireland. President - Irish Hyperlipidaemia Association and Director of Education, The Royal College of Physicians in Ireland. Guiseppe Danilo Norata Italy Giuseppe Danilo Norata is Associate Editor for Cardiovascular Research and for Atherosclerosis, Academic Editor of PLOS ONE and is a member of the Editorial Board of Nutrition Metabolism and Cardiovascular Disease.

7 7 Mahfouz Elshahawy. USA Professor Mahfouz is president of the International Society for Cardiovascular Disease Prevention. Master of Science, Medicine/Cardiovascular Diseases; Mayo Clinic University of Minnesota. Mekhman Mamedov Russia Dr. Mamedov is Head of the Laboratory for cardiovascular risk at the National Research Centre for Preventive Medicine; Vice-President of the Cardioprogress Foundation, and Deputy Chief Editor of the International Heart and Vascular Disease Journal..

8 8 Stephen Kopecky USA Dr. Stephen Kopecky is a cardiologist at Mayo Clinic, Past President of the American Society for Preventive Cardiology and is the 2013 recipient of the Jan J. Kellermann Memorial Award given by the International Academy of Cardiology for distinguished work in the field of Cardiovascular Disease Prevention. Winfried März Germany Prof. Winfried März is director Synlab Academy and Business Development Manager, Synlab Services, Ausgburg Associated Scientist, Medical Clinic V (Nephrology, Hypertensiology, Rheumatology, Endocrinology, Mannheim Institute of Public Health, Social and Preventive Medicine, Medical Faculty Mannheim, University of Heidelberg

9 9

10 10 Conference Venue Continental Hotel Hurghada is located, nestled in Hurghada Bay, directly on its own beach and with private access to the Red Sea. Only a ten-minute drive from Hurghada International Airport and a few minutes from the city center. The Continental Hurghada is nestled in Hurghada Bay, at the Southern end of town, directly on the famous promenade, a pedestrian road, locally known as the Mamsha. Housing All rooms are bed and breakfast at Continental Hotel Hilton Hotel Royal Lagoon Hotel Lunch and Dinner are only served upon coupons at Continental Hotel

11 11 Languages The official language is English. There will be no translation available Weather Electricity The electricity supply in Egypt is 220 Volts, 50 Hz. Most hotels also provide 110 Volts outlets for shavers

12 12 Registration Hours Registration desk will be ready on Wednesday 21 st of November at 14:00 Registration desk will be ready on Thursday, 22 nd of November at 14:0 0 Registration desk will be ready on Friday, 23 rd of November at 14:30 Badge All registrants and exhibitors must wear their name badge to have access to Conference sessions, lunches and social events. No exceptions will be made. Website

13 13 Food & Beverage All refreshments and Coffee Breaks activities will be served against coupon in the Conference kit. Each coupon is valid only for the meal mentioned on it and according to the timing mentioned below with no stop of the scientific program. Coffee Breaks will be available at Exhibition Area Coffee Breaks for Chairpersons and Speakers will be available at The Faculty Lounge Day Lunch Coffee Break Dinner Wednesday 21 st of November 13:00-15:00 18:25-18:45 22:00 Thursday 22 nd of November 13:00-15:00 18:05-18:20 22:00 Friday 23 rd of November 13:00-15:00 18:50-19:05 22:15

14 14 Audiovisual Instructions Dear Speaker, You will soon be presenting at CardioRisk Conference and we want this experience to go as smoothly as possible for you. On behalf of CardioRisk conference, ICOM will manage the audiovisual center and provide you with assistance before, during and after your presentation. * Please make sure that you received your personal program (by ), we also advise that you check the final program available online. * All speakers are required to submit their presentations at the audiovisual center. * Please make sure that you keep a copy of your presentation for backup. For Case Presentations All case presentations should be submitted at least 24 hours prior to the session Submitting your Presentation All presentations should be entirely in English. Microsoft Power Point, Apple Keynote and Prezi presentations are supported. Please submit your presentation on Flash Memory or CD/DVD. Please make sure that the presentation contains all media and video files included in your presentation. It s not allowed to use your personal laptop. Presentations should be submitted to the audiovisual center at least one hour before the start of your session to be able to prepare it. Inside The Hall Please arrive at the conference main hall at least 10 minutes prior to the beginning of your session. Thank you for abiding by the allocated duration of your presentation. A computerized countdown timer will be displayed on screen and will automatically close the presentation once the time is finished

15 15 15

16 16 16

17 Acknowledgement CardioRisk 2018 Expresses great gratitude to the following companies sharing in the activities and success of the conference 17 17

18 scientific Program 18 18

19 19 19 Wednesday 21 st of November 2018 Time - Halls Main Hall Exhibition Area 15:30-16:30 Rising Stars I Case Dialogue 16:35-17:35 Plenary I 17:40-18:25 Game Changing Trial I 18:25-18:45 Coffee Break 18:45-19:05 Key Note Lecture I 19:10-20:10 Dialogue Room I 20:15-20:45 Sanofi Symposium 20:50-21:10 Key Note Lecture II 21:10-21:50 Plenary II

20 20 20 Hall: Main Hall - 15:30-16:30 Ahmed Shawky Ossama Sanad Moderator El Sayed Farag Rising Stars I Case Dialogue Ashraf Reda 15:30-15:45 Haemorrhagic stroke in patient with AF Ahmed Gaber Ahmed El Gohary 15:45-15:50 Discussion 15:50-16:05 Diabetic Ketoacidosis in patients with ACS Mohamed Samak Ahmed Moustafa 16:05-16:10 Discussion 16:10-16:25 Resistant Hypertension Ahmed Naguib Ahmed Yehia 16:25-16:30 Discussion Menoufia National Research Center NHI Kafr El Sheikh Alexandria Alexandria

21 21 21 Hall: Main Hall - 16:35-17:35 Ahmad Al Sarraf Atef Elbahry Moderator Ahmed Shawky Plenary I Hypertension Ahmed El Kersh Mourad Beshay 16:35-16:47 Methods of BP measurements and what are the numbers? Ramzy Elmawardy 16:47-16:50 Discussion 16:50-17:02 Single pill combination from an option to a must. Yasser Huzayen 17:02-17:05 Discussion 17:05-17:17 How to choose Your RAAS Ahmed Shawky 17:17-17:20 Discussion 17:20-17:32 Cardiometabolic disorders Mekhman N Mamedov 17:32-17:35 Discussion Ain Shams Ain Shams Ain Shams Russia

22 22 22 Hall: Main Hall - 17:40-18:25 Ihab Attia Ragab Abdelsalam Moderator Tamer Moustafa Game Changing Trial I Ossama Sanad Walid Abdou 17:40-17:52 ODYSSEY OUTCOMES El Sayed Farag 17:52-17:55 Discussion 17:55-18:07 ASCEND Mohamed Al Tohfa 18:07-18:10 Discussion 18:10-18:22 CAMELLA- TIMI 61 Tamer Moustafa 18:22-18:25 Discussion Zagazig Damnhour Zagazig 18:25-18:45 Coffee Break

23 23 23 Hall: Main Hall - 18:45-19:05 Ashraf Reda Gerald Tomkin Key Note Lecture I Mekhman N Mamedov 18:45-19:00 Pharmarcokinetics: Does it really matter for choosing the correct statin Giuseppe Norata Italy 19:00-19:05 Discussion

24 24 24 Hall: Main Hall - 19:10-20:10 Andreas Zirlik Mohamed Abdelshafy Tabl Discussants (in alphabetical order) Amr Kamal Hany Ragy Moderator Hazem Khamis Dialogue Room I DAPT Dialogue El Sayed Farag Yasser Huzayen Ayman Aboul Magd 19:10-19:25 Optimal duration of DAPT in ACS Ayman Aboul Magd 19:25-19:30 Discussion 19:30-19:45 Preoperative management of DAPT in Clinical practice Hany Ragy 19:45-19:50 Discussion 19:50-20:05 DAPT with NOACs in AF Amr Kamal 20:05-20:10 Discussion Al Azhar NHI Alexandria

25 25 25 Hall: Main Hall - 20:15-20:45 Ahmed Shawky Atef Elbahry Sanofi Symposium Amr Kamal Ayman Aboul Magd 20:15-20:35 ACS and Beyond Tamer Moustafa 20:35-20:45 Discussion Zagazig

26 26 26 Hall: Main Hall - 20:50-21:10 Giuseppe Norata Ramzy Elmawardy Key Note Lecture II Mahfouz El Shahawy 20:50-21:05 Nutritional aspects in CV prevention Gerald Tomkin 21:05-21:10 Discussion Ireland

27 27 27 Hall: Main Hall - 21:10-21:50 Atef Elbahry Hany Ragy Stephen Kopecky Plenary II El Sayed Farag Nevine Samy 21:10-21:25 PCSK9-I: Lessons derived from clinical trial Mahfouz El Shahawy 21:25-21:30 Discussion 21:30-21:45 Fasting vs non Fasting lipid profile Ahmad Al Sarraf 21:45-21:50 Discussion USA Kuwait 21:50-22:45 Dinner

28 28 28 Thursday 22 nd of November 2018 Time - Halls Main Hall Exhibition Area 15:00-15:45 Game Changing Trial II 15:50-16:45 2 nd Annual Joint Session with The German Atherosclerosis Society Inflammation and Atherosclerosis 16:45-17:15 Sanofi Symposium 17:20-18:05 Dialogue Room II 18:05-18:20 Coffee Break 18:20-18:50 Servier Symposium 18:55-19:35 Plenary III 19:40-20:40 EAVA PCSK 9 Summit 20:45-21:05 Key Note Lecture III 21:10-21:50 Joint Session AASD

29 29 29 Hall: Main Hall - 15:00-15:45 Ahmad Boghday Mohamed Sobhy Moderator Tamer Moustafa Game Changing Trial II Ahmed Rozza Naser Taha 15:00-15:12 Qualify Adel El Etriby 15:12-15:15 Discussion 15:15-15:27 ARRIVE Tamer Moustafa 15:27-15:30 Discussion 15:30-15:42 GLOBAL LEADERS Ramez Guindy 15:42-15:45 Discussion Ain Shams Zagazig Ain Shams

30 30 30 Hall: Main Hall - 15:50-16:45 2 nd Annual Joint Session with The German Atherosclerosis Society Inflammation and Atherosclerosis Gamal Abo Elnasr Hazem Khamis Ihab Attia Mekhman N Mamedov Moderator Ashraf Reda 15:50-15:55 Introduction Ashraf Reda 15:55-16:07 Residual risk and inflammarion Atef Elbahry 16:07-16:10 Discussion 16:10-16:22 Biomarkers of atherosclerosis Ahmed Shawky 16:22-16:25 Discussion 16:25-16:40 Anti- inflammatory strategies Andreas Zirlik 16:40-16:45 Discussion Menoufia Port Said Ain Shams Germany

31 31 31 Hall: Main Hall - 16:45-17:15 Ashraf Reda Mohamed Sobhy Yasser Bahnasy Sanofi Symposium Ihab Attia Tarek Abdel Ghaffar 16:45-17:05 High risk ACS patient El Sayed Farag 17:05-17:15 Discussion Zagazig

32 32 32 Hall: Main Hall - 17:20-18:05 Dialogue Room II The Triglyceride Dialogue Ayman Kaddah Khaled El Nady Mohamed Seleem Discussants (in alphabetical order) Ahmed Tag Karim Said Yaser Boughdady Moderator Atef Elbahry 17:20-17:25 Introduction Atef Elbahry Port Said 17:25-17:35 Q1: Do we need to reassess the contribution of triglycerides to the residual risk? Karim Said Cairo 17:35-17:38 Discussion

33 :38-17:48 Q2: Triglycerides in the guidelines Ahmed Tag 17:48-17:51 Discussion 17:51-18:01 Q3: Are statins enough for reducing TG in ASCVD? Yaser Boughdady 18:01-18:05 Discussion Suez Canal Cairo Hall: - 18:05-18:20 Coffee Break

34 34 34 Hall: Main Hall - 18:20-18:50 Ashraf Reda Mahmoud Shah Servier Symposium Gamila Mohamed Nasr 18:20-18:30 Numbers always say the truth, BUT! Ayman Saleh 18:30-18:35 Discussion 18:35-18:45 Filling the gap in hypertension management Hossam Kandil 18:45-18:50 Discussion Ain Shams Cairo

35 35 35 Hall: Main Hall - 18:55-19:35 Plenary III Management of Atherosclerosis Beyond Statin Adel El Etriby Hossam Kandil Mohamed Sobhy Montasser El Sekely Nosehy Yousef Sameh Shahin 18:55-19:10 Inflamtion and Atherothrombosis: current prospects and uture direcrions Andreas Zirlik Germany 19:10-19:15 Discussion 19:10-19:25 Gene Silencing approaches for the management of dyslipidemia Giuseppe Norata Italy 19:25-19:30 Discussion

36 36 36 Hall: Main Hall - 19:40-20:40 Ahmed Shawky Ashraf Reda Islam Saifelyazal EAVA PCSK 9 Summit Ahmed Yehia Hegab El Sayed Farag 19:40-19:52 Genetics of PCSK 9: An Over View Winfried Marz Germany 19:52-19:55 Discussion 19:55-20:07 Molecular Insight Into The Intracellular Actions Of PCSK9 Atef Elbahry Port Said 20:07-20:10 Discussion 20:10-20:22 PCSK9 beyond LDL-C lowering: what s new? Giuseppe Norata Italy 20:22-20:25 Discussion 20:25-20:40 Evolocumab: New Frontier in Cholesterol Management Ashraf Reda Menoufia

37 37 37 Hall: Main Hall - 20:45-21:05 Aly Saad Khaled El Tohamy Moustafa Mokarab Key Note Lecture III Kamal Mahmoud Magdy Mattar Omer Elbahei 20:45-21:00 Value & limitation of early screening to detect familial hypercholesterolemia Stephen Kopecky USA 21:00-21:05 Discussion

38 38 38 Hall: Main Hall - 21:10-21:50 Ahmed El Ghalid Ossama Sanad Joint Session AASD Hesham Rashid Raafat Rashwan 21:10-21:25 Diabetes Geriatric Time Inass Shaltout 21:25-21:30 Discussion 21:30-21:45 Insuline Usage in Cardiac Patients Amr Abdel Wahab 21:45-21:50 Discussion Cairo Cairo 22:00-22:45 Dinner

39 39 39 Friday 23 rd of November 2018 Time - Halls Main Hall Exhibition Area 15:00-15:50 Rising Stars II (Education by Competition) 15:55-16:40 Dialogue Room III The Future of Lipid Lowering and Emerging Therapies 16:45-17:25 Plenary IV 17:30-18:20 Dialogue Room IV 18:20-18:50 AstraZeneca Symposium 18:50-19:05 Coffee Break 19:05-20:05 Plenary V Herat Failure (Novartis Symposium) 20:10-20:40 MSD Symposium 20:45-21:30 Plenary VI 21:30-22:15 Game Changing Trial III

40 40 Hall: Main Hall - 15:00-15:50 Rising Stars II (Education by Competition) MCQs Cardiovascular Risk Factors Mohamed Sadaka Mohamed Seleem Sharaf Ashazly Waleed Ammar Yasser Huzayen Moderator El

40 40 40 Hall: Main Hall - 15:00-15:50 Rising Stars II (Education by Competition) MCQs Cardiovascular Risk Factors Mohamed Sadaka Mohamed Seleem Sharaf Ashazly Waleed Ammar Yasser Huzayen Moderator El Sayed Farag 15:00-15:10 Hypertension Shehab El Etriby Ain Shams 15:10-15:20 Diabetes Kareem Mahmoud Cairo 15:20-15:30 Dyslipidaemia Ahmed Elbendary Banha 15:30-15:40 Smoking Mohamed Abdelshafy Tabl Banha 15:40-15:50 Family history of CVD Hesham Refaat Zagazig The Prize Will Be Full Sponsorship for The Coming BCC 5 For The First 10 Winners

41 41 41 Hall: Main Hall - 15:55-16:40 Dialogue Room III The Future of Lipid Lowering and Emerging Therapies Ihab Daoud Hanna Khaled El Nady Mohamed Gamal Discussants (in alphabetical order) Alaa Etman Amr El Hadidy Moderator Mohamed Seleem Seif Kamal Abou Seif Amin Fouad 15:55-16:07 Residual risk, more lowering of LDL or new targets? Alaa Etman NHI 16:07-16:10 Discussion 16:10-16:22 The heavy rock, how we can elevate the HDL Amr El Hadidy Cairo 16:22-16:25 Discussion 16:25-16:37 Extreme risk and very high risk, any evidence to support this distinction Amin Fouad Military Academy 16:37-16:40 Discussion

42 42 42 Hall: Main Hall - 16:45-17:25 Andreas Zirlik Hossam Kandil Saeid Shalaby Plenary IV Hesham Aboul Einen Medhat El Ashmawy Sameh Emil Sadek Zaki 16:45-17:00 Genetics in cardiovascular prevention: from pure science to clinical practice Winfried Marz Germany 17:00-17:05 Discussion 17:05-17:20 LP(a) and residual risk Ihab Attia Ain Shams 17:20-17:25 Discussion

43 43 43 Hall: Main Hall - 17:30-18:20 Ahmed Abdellatif Ramadan El Sayed Abdel Khalek Discussants (in alphabetical order) Adel El Etriby Mohamed Sadaka Moderator El Sayed Farag Dialogue Room IV Atherothrombosis Diaa El Menshawy Tarek Zaky Ahmed Elbendary 17:35-17:47 Can we prevent the cryptogenic stroke? Adel El Etriby Ain Shams 17:47-17:50 Discussion 17:50-18:02 AMI, is it always with significant atherosclerosis? Ahmed Elbendary Banha 18:02-18:05 Discussion 18:05-18:17 Anticoagulants to prevent atherothrombotic events,what's new? Mohamed Sadaka Alexandria 18:17-18:20 Discussion

44 44 44 Hall: Main Hall - 18:20-18:50 AstraZeneca Symposium Amr El Hadidy Hazem Khamis Moustafa Elsayed Nerine Okasha 18:20-18:40 Optimised ACS care throughout the patient journey Ahmed Shawky Ain Shams 18:40-18:50 Discussion Hall: - 18:50-19:05 Coffee Break

45 45 45 Hall: Main Hall - 19:05-20:05 Ahmed Abdelmoneim Samia Elkady Moderator Ossama Sanad Novartis Symposium Plenary V Heart Failure Ahmad Boghdady Tarek Naguib 19:05-19:17 The past, the present, and the future of natriuretic peptides in the diagnosis of heart failure Mahmoud Hassanein Alexandria 19:17-19:20 Discussion 19:20-19:32 New hope to diagnose the mysterious HFpEF Mohamed Seleem NHI 19:32-19:35 Discussion 19:35-19:55 Entresto: New hope in management of heart failure Ossama Sanad Banha 19:55-20:05 Discussion

46 46 46 Hall: Main Hall - 20:10-20:40 Alaa El Ghamrawy William Moris MSD Symposium Samir Rafla 20:10-20:30 Impact & Evaluation of Dual Lipid- Lowering Strategy with Ezetimibe and Statins Post Improve It Atef Elbahry Port Said 20:30-20:40 Discussion

47 47 47 Hall: Main Hall - 20:45-21:30 Magdy Abdel Samea Tarek El Khouly Moderator Atef Elbahry Plenary VI Vascular Biology Tarek Abdel Moneim Yaser Boughdady 20:45-20:57 Manipulating T-Cells as Therapeutic Target After MI Abdel Moneim Ibrahim Ahmed Cairo 20:57-21:00 Discussion 21:00-21:12 Role of Platelets in Inflammation & Atherogenesis Sanaa Abdel Shafy Cairo 21:12-21:15 Discussion 21:15-21:27 Basic Aspects of Plaque Vulnerability (Rupture Vs Erosion) Atef Elbahry Port Said 21:27-21:30 Discussion

48 48 48 Hall: Main Hall - 21:30-22:15 Abdel Rahman Sharaf Ahmed Kamal Motawea Mourad Beshay Moderator Tamer Moustafa 21:30-21:40 SMART DATE Mohamed Gamal 21:40-21:45 Discussion 21:45-21:55 COMMANDER HF Tarek El Zawawy 21:55-22:00 Discussion 22:00-22:10 REVASC Walid Elawady 22:10-22:15 Discussion Game Changing Trial III Abdel Salam Sherif Hamza Kabil Assiut Alexandria Zagazig 22:15-23:00 Dinner

CardioRisk nd 23 rd November 2017 The Egyptian Association of Vascular Biology and Atherosclerosis الجمعية المصرية لتصلب شرايين القلب

CardioRisk nd 23 rd November 2017 The Egyptian Association of Vascular Biology and Atherosclerosis الجمعية المصرية لتصلب شرايين القلب 1 CardioRisk 2017 22 nd 23 rd November 2017 The Egyptian Association of Vascular Biology and Atherosclerosis الجمعية المصرية لتصلب شرايين القلب Endorsed By 2 Contents Welcome Note About EAVA & CardioRisk